Effects of sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients.

Ryutaro MoritaShunichiro TsukamotoShota ObataTakayuki YamadaKazushi UnedaTatsuki UeharaMuhammad Ebad RehmanKengo AzushimaHiromichi WakuiKouichi Tamura

Published in: Diabetes, obesity & metabolism (2023)

Combination therapy with SGLT2-Is and MRAs was associated with lower albuminuria in patients with type 2 DM compared with monotherapy with SGLT2-Is or MRAs alone.

Keyphrases

combination therapy
randomized controlled trial
clinical trial
metabolic syndrome
adipose tissue
study protocol
open label